Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001493152-25-008412
Filing Date
2025-02-26
Accepted
2025-02-26 21:20:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5382
  Complete submission text file 0001493152-25-008412.txt   7008
Mailing Address 311 QUIET HILL LANE WOODSTOCK GA 30189
Business Address
Friedman Lance (Filed by) CIK: 0001470622 (see all company filings)

Type: SCHEDULE 13G

Mailing Address 194 CANDELARO DRIVE, #233 HUMACAO PR 00791
Business Address 194 CANDELARO DRIVE, #233 HUMACAO PR 00791 561-704-8527
Aspire Biopharma Holdings, Inc. (Subject) CIK: 0001847345 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-93583 | Film No.: 25672442
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)